伦敦初创公司Limbic近日宣布，其在A轮融资中成功募集1400万美元，这标志着这家人工智能治疗助理企业的发展迈入新阶段。本轮融资由知名投资机构Khosla Ventures领投，Gaingels和Illusian等投资者跟投。Limbic成立于2018年，专注于利用AI技术革新心理健康服务领域。
Limbic的核心产品是一款人工智能心理健康聊天机器人，以及一套基于AI的临床转诊软件。这款聊天机器人已经在英国国家医疗服务体系（NHS）中广泛应用，覆盖了大约26万名患者，占英国NHS谈话治疗服务的33%。这一成就凸显了Limbic的技术在改善心理健康服务效率和可及性方面的潜力。
随着这笔资金的注入，Limbic计划加速其产品在美国市场的推广。此举旨在满足美国不断增长的心理健康服务需求，利用AI技术为患者提供更个性化、及时和有效的治疗方案。Limbic的扩张将可能改变全球心理健康领域的服务模式，让更多人受益于AI驱动的创新疗法。
英语如下：
**News Title:** “Limbic, an AI-Powered Mental Health Company in London, Raises $14M in Series A Funding to Expand into the US Market”
**Keywords:** AI therapy, Limbic, $14 million funding
**News Content:** London-based startup Limbic has recently announced that it has successfully raised $14 million in its Series A funding round, signaling a new phase of growth for the artificial intelligence-assisted therapy company. The round was led by prominent venture capital firm Khosla Ventures, with participation from Gaingels and Illusian among other investors.
Founded in 2018, Limbic focuses on revolutionizing mental health services through AI technology. The company’s flagship product is an AI-powered mental health chatbot, coupled with AI-driven clinical referral software. This chatbot has been extensively deployed within the UK’s National Health Service (NHS), assisting approximately 260,000 patients, which constitutes 33% of the NHS’s talking therapy services. This demonstrates the potential of Limbic’s technology in enhancing the efficiency and accessibility of mental health care.
With this injection of capital, Limbic aims to accelerate the rollout of its products in the US market. This move is targeted at addressing the increasing demand for mental health services in the country, leveraging AI to offer more personalized, timely, and effective treatment options. Limbic’s expansion has the potential to reshape the global landscape of mental health service delivery, making AI-driven innovative therapies accessible to a larger population.
【来源】https://sifted.eu/articles/limbic-series-a-14m-ai-chatbot-news
Views: 1